1. Home
  2. BZUN vs IPHA Comparison

BZUN vs IPHA Comparison

Compare BZUN & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Baozun Inc.

BZUN

Baozun Inc.

HOLD

Current Price

$3.08

Market Cap

164.5M

ML Signal

HOLD

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

N/A

Current Price

$1.61

Market Cap

165.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BZUN
IPHA
Founded
2007
1999
Country
China
France
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
164.5M
165.3M
IPO Year
2014
2014

Fundamental Metrics

Financial Performance
Metric
BZUN
IPHA
Price
$3.08
$1.61
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
★ $5.75
AVG Volume (30 Days)
★ 169.8K
38.0K
Earning Date
05-20-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7.89
$180.36
Revenue Next Year
$6.16
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.07
$1.18
52 Week High
$4.25
$2.71

Technical Indicators

Market Signals
Indicator
BZUN
IPHA
Relative Strength Index (RSI) 62.46 32.42
Support Level $2.66 $1.34
Resistance Level $3.23 $1.83
Average True Range (ATR) 0.12 0.10
MACD 0.03 -0.03
Stochastic Oscillator 71.00 9.84

Price Performance

Historical Comparison
BZUN
IPHA

About BZUN Baozun Inc.

Baozun Inc is engaged to provide its customers with end-to-end e-commerce solutions including the sales of apparel, home and electronic products, online store design and setup, visual merchandising and marketing, online store operations, customer services, warehousing and order fulfillment, as well as the holistic brand management, including tactic positioning, branding and marketing, retail and e-commerce operations, supply chain and logistics, and technology empowerment. It has two operating segments: E-Commerce (encompassing BEC and BZI) and Brand Management (representing BBM). The company generates maximum of its revenue from E-Commerce (encompassing BEC and BZI) segment.

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. The company's approach includes therapeutic modalities such as monoclonal antibodies, multispecific NK cell engagers through its ANKET platform, and antibody-drug conjugates (ADC). Its portfolio includes lacutamab, which is being studied for cutaneous T-cell lymphomas and peripheral T-cell lymphomas, and monalizumab, which is being developed in collaboration with AstraZeneca for non-small cell lung cancer. The company's revenue mainly consists of revenues from collaboration and licensing agreements and government financing for research expenditure in the form of research tax credits, as well as other grants.

Share on Social Networks: